Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment

Fully automated opportunistic screening of vertebral fractures and osteoporosis on more than 150 000 routine computed tomography scans

Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents Study

Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse events

Nevirapine Use Is Associated with Higher Bone Mineral Density in HIV-1 Positive Subjects on Long-Term Antiretroviral Therapy

Measurement of Trabecular Bone Score of the Spine by Low-Dose Imaging System (EOS(®)): A Feasibility Study

Abdominal adipose tissue predicts major cardiovascular events in systemic necrotising vasculitides

Ultrasound-Based Estimates of Cortical Bone Thickness and Porosity Are Associated With Nontraumatic Fractures in Postmenopausal Women: A Pilot Study

Vertebral strength prediction from Bi-Planar dual energy x-ray absorptiometry under anterior compressive force using a finite element model: An in vitro study

High bone mass in adults

Sagittal balance of the spine in patients with osteoporotic vertebral fractures

Vertebral strength prediction under anterior compressive force using a finite element model for osteoporosis assessment

Diagnosis of vertebral fractures using a low-dose biplanar imaging system

Dr. Hmamouchi, et al reply

Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study

Usefulness of bone density measurement in fallers

Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatment

TBS result is not affected by lumbar spine osteoarthritis

Oxytocin, a new determinant of bone mineral density in post-menopausal women: analysis of the OPUS cohort

Difficulties in the diagnosis of vertebral fracture in men: agreement between doctors

Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia

Prospective assessment of bone texture parameters at the hand in rheumatoid arthritis

Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: the OPUS study

2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis

Identification of rheumatoid arthritis patients with vertebral fractures using bone mineral density and trabecular bone score

Fat tissue distribution changes in HIV-infected patients treated with lopinavir/ritonavir. Results of the MONARK trial

Prospective one-year bone loss in treatment-naïve HIV+ men and women on single or multiple drug HIV therapies

Underweight patients with anorexia nervosa: comparison of bioelectrical impedance analysis using five equations to dual X-ray absorptiometry

Increase in vertebral body size in postmenopausal women with osteoporosis

Lopinavir/ritonavir monotherapy versus current treatment continuation for maintenance therapy of HIV-1 infection: the KALESOLO trial

Prospective assessment of thoracic kyphosis in postmenopausal women with osteoporosis

Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients

Radiographic methods for evaluating osteoporotic vertebral fractures

Increase in vertebral fracture risk in postmenopausal women using omeprazole

Spinal deformity index (SDI) is a good predictor of incident vertebral fractures

Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis

Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial

Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response

Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study

Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM)

Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120)

The French multicentre elevated bone mass study: prevalence and causes

Prevalence and causes of elevated bone mass

Prevalence of low bone mineral density in men and women infected with human immunodeficiency virus 1 and a proposal for screening strategy

Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids

[Bone mineral density interpretation, FRAX calculation]

Adjusting FRAX® on TBS for identification of subjects at high risk of fractures

FRAX®: prediction of major osteoporotic fractures in women from the general population: the OPUS study

Bone mineral density and bone remodeling markers in chronic low back pain patients with active discopathy: A case-control exploratory study

Absence of relationships between depression and anxiety and bone mineral density in patients hospitalized for severe anorexia nervosa